Logo image of VATE

INNOVATE CORP (VATE) Stock Fundamental Analysis

NYSE:VATE - New York Stock Exchange, Inc. - US45784J3032 - Common Stock - Currency: USD

10.81  -1.51 (-12.26%)

After market: 10.85 +0.04 (+0.37%)

Fundamental Rating

1

VATE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 48 industry peers in the Construction & Engineering industry. Both the profitability and financial health of VATE have multiple concerns. VATE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

VATE had negative earnings in the past year.
In the past year VATE had a positive cash flow from operations.
VATE had negative earnings in each of the past 5 years.
Of the past 5 years VATE 4 years had a positive operating cash flow.
VATE Yearly Net Income VS EBIT VS OCF VS FCFVATE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M -200M 300M

1.2 Ratios

With a Return On Assets value of -3.18%, VATE is not doing good in the industry: 80.43% of the companies in the same industry are doing better.
VATE's Return On Invested Capital of 10.05% is fine compared to the rest of the industry. VATE outperforms 76.09% of its industry peers.
Industry RankSector Rank
ROA -3.18%
ROE N/A
ROIC 10.05%
ROA(3y)-9.47%
ROA(5y)-6.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VATE Yearly ROA, ROE, ROICVATE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 300

1.3 Margins

With a Operating Margin value of 4.43%, VATE perfoms like the industry average, outperforming 43.48% of the companies in the same industry.
VATE has a Gross Margin of 18.15%. This is comparable to the rest of the industry: VATE outperforms 50.00% of its industry peers.
VATE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.43%
PM (TTM) N/A
GM 18.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.37%
GM growth 5Y-5.18%
VATE Yearly Profit, Operating, Gross MarginsVATE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

1

2. Health

2.1 Basic Checks

VATE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for VATE has been reduced compared to 1 year ago.
Compared to 5 years ago, VATE has less shares outstanding
Compared to 1 year ago, VATE has a worse debt to assets ratio.
VATE Yearly Shares OutstandingVATE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
VATE Yearly Total Debt VS Total AssetsVATE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

VATE has an Altman-Z score of 0.78. This is a bad value and indicates that VATE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of VATE (0.78) is worse than 89.13% of its industry peers.
The Debt to FCF ratio of VATE is 54.89, which is on the high side as it means it would take VATE, 54.89 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 54.89, VATE is doing worse than 69.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 54.89
Altman-Z 0.78
ROIC/WACC1.39
WACC7.21%
VATE Yearly LT Debt VS Equity VS FCFVATE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

VATE has a Current Ratio of 0.85. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of VATE (0.85) is worse than 86.96% of its industry peers.
VATE has a Quick Ratio of 0.85. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
VATE has a worse Quick ratio (0.81) than 84.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.81
VATE Yearly Current Assets VS Current LiabilitesVATE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

0

3. Growth

3.1 Past

VATE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -275.44%.
VATE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.30%.
VATE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.36% yearly.
EPS 1Y (TTM)-275.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1211.09%
Revenue 1Y (TTM)-16.3%
Revenue growth 3Y25.68%
Revenue growth 5Y-6.36%
Sales Q2Q%-35.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VATE Yearly Revenue VS EstimatesVATE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B
VATE Yearly EPS VS EstimatesVATE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VATE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VATE Price Earnings VS Forward Price EarningsVATE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VATE is valued cheaply inside the industry as 93.48% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, VATE is valued cheaply inside the industry as 80.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.38
EV/EBITDA 8.94
VATE Per share dataVATE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VATE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVATE CORP

NYSE:VATE (2/21/2025, 8:04:00 PM)

After market: 10.85 +0.04 (+0.37%)

10.81

-1.51 (-12.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-03 2025-03-03
Inst Owners21.32%
Inst Owner Change-95.01%
Ins Owners52.74%
Ins Owner Change-102.83%
Market Cap143.34M
Analysts82.86
Price TargetN/A
Short Float %10.25%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)-23.48%
DP-4.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF 11.38
P/OCF 4.96
P/B N/A
P/tB N/A
EV/EBITDA 8.94
EPS(TTM)-0.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.95
FCFY8.79%
OCF(TTM)2.18
OCFY20.16%
SpS92.87
BVpS-11.09
TBVpS-33.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.18%
ROE N/A
ROCE 12.72%
ROIC 10.05%
ROICexc 11.41%
ROICexgc 55.51%
OM 4.43%
PM (TTM) N/A
GM 18.15%
FCFM 1.02%
ROA(3y)-9.47%
ROA(5y)-6.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.37%
GM growth 5Y-5.18%
F-Score5
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 54.89
Debt/EBITDA 5.73
Cap/Depr 49.24%
Cap/Sales 1.32%
Interest Coverage 1.11
Cash Conversion 32.95%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.81
Altman-Z 0.78
F-Score5
WACC7.21%
ROIC/WACC1.39
Cap/Depr(3y)54.75%
Cap/Depr(5y)66.28%
Cap/Sales(3y)1.52%
Cap/Sales(5y)2.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-275.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1211.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.3%
Revenue growth 3Y25.68%
Revenue growth 5Y-6.36%
Sales Q2Q%-35.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y155.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122.5%
FCF growth 3Y-43.16%
FCF growth 5Y-51.5%
OCF growth 1Y194.44%
OCF growth 3Y-24.63%
OCF growth 5Y-40.02%